This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.89% per year. These returns cover a period from January 1, 1988 through March 3, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Analyst Blog: Archive
Watch These 5 Medical Stocks for Q1 Earnings: Beat or Miss?
by Debasmita Chatterjee
Improved premiums resulting from membership growth, and higher patient admissions are expected to have driven the Q1 performance of HUM, MOH, UHS, EHC and CYH. An elevated operating expense level is likely to have dented growth prospects.
UHSPositive Net Change HUMPositive Net Change MOHPositive Net Change CYHPositive Net Change EHCPositive Net Change
earnings medical
What's in Store for These 4 Medical Products Stocks in Q1 Earnings?
by Zacks Equity Research
Medical Products companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO, ALGN and ICLR fare this time.
BSXPositive Net Change ALGNPositive Net Change TMOPositive Net Change ICLRPositive Net Change
earnings medical medical-devices
5 Construction Stocks Likely to Beat Q1 Earnings Estimates
by Zacks Equity Research
URI, KBR, BCC, LPX & DFH from the Zacks Construction sector are set to beat analysts' expectations on the back of a solid housing market scenario amid labor woes.
KBRPositive Net Change LPXPositive Net Change URIPositive Net Change BCCPositive Net Change DFHPositive Net Change
construction earnings home-builder
Can These 3 Internet Software Stocks Hit Q1 Earnings Targets?
by Vasundhara Sawalka
Here, we take a sneak peek at some Internet Software stocks, PERF, META and TWOU, which are gearing up to report first-quarter 2024 earnings.
TWOUPositive Net Change METAPositive Net Change PERFPositive Net Change
artificial-intelligence internet saas tech-stocks
Can These 4 Auto Retailers Beat Q1 Earnings Expectations?
by Rimmi Singhi
Our proven model doesn't conclusively predict an earnings beat for GPI, LAD, AN and PAG in Q1, as they don't have the right combination of a favorable Zacks Rank and a positive Earnings ESP.
GPCPositive Net Change PAGNegative Net Change ANPositive Net Change GPIPositive Net Change LADPositive Net Change
auto-tires-trucks earnings
Will These 4 Semiconductor Stocks Beat Forecasts This Earnings?
by Anirudha Bhagat
Here we take a sneak peek into how these semiconductor stocks - LRCX, SLAB, MXL and PI - are poised ahead of their earnings releases.
LRCXPositive Net Change SLABPositive Net Change MXLPositive Net Change PIPositive Net Change
computers earnings semiconductor tech-stocks
What's in Store for These 5 Transportation Stocks in Q1 Earnings?
by Maharathi Basu
Let's focus on transportation stocks like UPS, NSC, UNP, LUV and AAL, which are scheduled to release first-quarter 2024 earnings shortly.
LUVPositive Net Change UNPPositive Net Change NSCPositive Net Change UPSPositive Net Change AALPositive Net Change
airlines transportation
Watch These 5 Technology Stocks for Q1 Earnings: Beat or Miss?
by Zacks Equity Research
Here is a sneak peek into how five technology stocks, MANH, MSCI, AEYE, HBIO and TXN, are expected to fare in their quarterly results slated to be released on Apr 23.
TXNPositive Net Change MSCIPositive Net Change MANHPositive Net Change HBIOPositive Net Change AEYEPositive Net Change
earnings tech-stocks
Are These 4 Beverage Stocks Poised to Hit Q1 Earnings Targets?
by Rajani Lohia
Players in the beverage industry are expected to have witnessed positive trends from expanded digital platforms and strong demand for innovative products in the to-be-reported quarter. Inflationary cost pressures, particularly higher input costs, are likely to have hurt.
FMXNegative Net Change PEPPositive Net Change SAMNegative Net Change KDPPositive Net Change
consumer-staples
Utility Stocks Reporting Q4 Earnings on Feb 27: AEP, SRE & PNW
by Tanvi Sarawagi
Let's focus on utilities like AEP, SRE and PNW, which are scheduled to release fourth-quarter 2023 earnings on Feb 27.
SREPositive Net Change AEPPositive Net Change PNWPositive Net Change
utilities
Biotech/Drug Stocks Q4 Earnings Due Feb 22: MRNA, BHC, NTLA, BMRN & More
by Ekta Bagri
Let us take a look at what's in store for biotech/drug stocks MRNA, BHC, NTLA, BMRN and ITCI, which are scheduled to report on Feb 22.
BMRNNegative Net Change MRNAPositive Net Change NTLAPositive Net Change BHCPositive Net Change
biotechnology biotechs earnings pharmaceuticals
Utility Stocks' Earnings to Watch on Feb 22: D, PCG & More
by Aparajita Dutta
Total fourth-quarter earnings of Utility stocks are expected to improve 15.3% year over year on a decline of 4.7% in revenues. Let's see how D, PCG, EIX, AEE, ETR & CWEN perform this time around.
AEENegative Net Change ETRPositive Net Change EIXPositive Net Change PCGPositive Net Change DPositive Net Change CWENPositive Net Change
earnings utilities
Energy Stocks' Q4 Earnings Roster for Feb 21: WES, APA & MRO
by Urbashi Dutta
Lower commodity prices are likely to have affected the upstream businesses. Let us see how Western Midstream (WES), APA Corp (APA) and Marathon Oil (MRO) are placed ahead of Q4 earnings.
MROPositive Net Change APAPositive Net Change WESNegative Net Change
energy oil-energy
Drug, Biotech Stock Q4 Earnings Due on Feb 15: ALNY, BPMC & More
by Zacks Equity Research
Let's look at five biotech/drug companies, ALNY, BPMC, AGIO, CORT and RARE, slated to release quarterly results on Feb 15.
ALNYPositive Net Change CORTPositive Net Change AGIOPositive Net Change RAREPositive Net Change BPMCPositive Net Change
biotechnology biotechs earnings medical pharmaceuticals
Medical Products Stocks' Earnings Due on Feb 15: WST, ITGR & More
by Debanjana Dey
Medical Products companies' quarterly results are likely to reflect strength in customer demand. Let's see how ITGR, WST, AMN and PACB are placed ahead of their earnings releases.
AMNPositive Net Change WSTPositive Net Change PACBPositive Net Change ITGRNegative Net Change
earnings medical medical-devices
Drug, Biotech Stocks' Q4 Earnings Due on Feb 13: BIIB, ZTS & INCY
by Zacks Equity Research
Let's take a look at three biotech/drug companies, BIIB, ZTS, and INCY, slated to release quarterly results on Feb 13.
BIIBPositive Net Change INCYNegative Net Change ZTSPositive Net Change
biotechs medical
Medical Device Stocks' Earnings Due on Feb 13: ECL, DVA & QDEL
by Indrajit Bandyopadhyay
Medical Device companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how ECL, DVA and QDEL fare this time.
ECLPositive Net Change DVANegative Net Change QDELPositive Net Change
medical medical-devices
Aerospace & Defense Stocks to Post Earnings on Feb 13: LDOS & KTOS
by Aparajita Dutta
Earnings from the Aerospace sector, which houses the aerospace & defense stocks, are expected to have improved 10.1% from the prior-year quarter's reported figure. Let's see how LDOS & KTOS report.
KTOSPositive Net Change LDOSPositive Net Change
aerospace earnings
Utility Stocks Reporting Q4 Earnings on Feb 8: FE, DUK & DTE
by Tanvi Sarawagi
Let's focus on utilities like FE, DUK and DTE, which are scheduled to release fourth-quarter 2023 earnings on Feb 8.
FEPositive Net Change DUKPositive Net Change DTEPositive Net Change
utilities
Medical Products Stocks' Earnings Due on Feb 7: STE, PAHC & NVST
by Urmimala Biswas
Medical Products companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how STE, PAHC and NVST fare this time.
STEPositive Net Change PAHCPositive Net Change NVSTPositive Net Change
earnings medical
Insurance Stocks to Post Q4 Earnings on Feb 7: RDN, EG & More
by Sushmita Sarker
Favorable reserve development, prudent underwriting, exposure growth across business lines and improved pricing, partly offset by catastrophe losses, are likely to have influenced the fourth-quarter performances of RDN, EG, FAF, SLF and ALL.
ALLPositive Net Change FAFPositive Net Change RDNPositive Net Change SLFPositive Net Change EGPositive Net Change
insurance
Insurance Stocks' Q4 Earnings Due on Feb 6: WTW, PRU & More
by Tanuka De
Insurers like WTW, PRU, AIZ, CINF and AFG are due to report fourth-quarter 2023 earnings tomorrow. Let's see what's in store for them.
PRUPositive Net Change CINFPositive Net Change AIZPositive Net Change AFGPositive Net Change WTWPositive Net Change
earnings insurance
Drug, Biotech Stocks' Q4 Earnings Due on Feb 6: AMGN, LLY & More
by Zacks Equity Research
Let's take a look at four biotech, drug companies, AMGN, LLY, GILD and EXEL, slated to release quarterly results on Feb 6.
LLYPositive Net Change AMGNNegative Net Change GILDPositive Net Change EXELPositive Net Change
biotechs medical
Medical Device Stocks' Earnings on Feb 1: RVTY, CAH & More
by Debanjana Dey
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how CAH, RVTY, CNMD, SRDX and BDX are placed ahead of their earnings releases.
BDXNegative Net Change CNMDPositive Net Change CAHPositive Net Change SRDXPositive Net Change RVTYPositive Net Change
earnings medical medical-devices
Insurance Stocks' Q4 Earnings Due on Jan 31: AFL, MET & More
by Tanuka De
Better pricing, solid retention and renewals, exposure growth and accelerated digitalization are likely to drive fourth-quarter results of insurers like AFL, MET, AXS, SIGI and MTG.
MTGPositive Net Change METPositive Net Change AFLPositive Net Change AXSPositive Net Change SIGIPositive Net Change
earnings insurance